Skip to main content
SpringerLink
Log in

Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours

Preferential reactivity with malignant tumours

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

We studied a wide range thyroid tumours and non-neoplastic conditions (total 463 cases) immunohistochemically to evaluate the possible diagnostic potential of HBME-1 and CD15 antibodies. HBME-1 monoclonal antibody recognizes a biochemically unknown epitope present in mesothelioma and variably present in some adenocarcinomas. CD15 antibodies recognize a sugar epitope also included in Lewis X blood group antigen. All papillary (145/145) and follicular carcinomas (27/27) were HBME-1 positive, usually in the the majority of tumour cells. In contrast, cases of nodular goitre and papillary hyperplasia either showed no reactivity or were focally positive (in a third of cases). The patterns of CD15 reactivity were generally similar, although smaller numbers of tumour cells were positive in papillary carcinomas, and only 50% of follicular carcinomas were positive. Because fetal thyroid also showed CD15 reactivity, this antigen appears to behave as an oncofetal antigen in relation to thyroid tissue. Anaplastic carcinomas were negative with both antibodies, indicating the loss of these epitopes upon high grade malignant transformation. We conclude that HBME-1 and CD15 immunohistochemistry may be helpful in the histological differential diagnosis between benign lesions and differentiated thyroid carcinomas, especially papillary tumours. Although the biochemical basis of HBME-1 reactivity is unknown, increased CD15 reactivity in malignant thyroid tumours probably reflects changes in thyroid follicular epithelial glycoconjugates related to malignant transformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arber DA, Weiss LM (1993) CD15. A review. Appl Immunohistochem 1:17–30

    Google Scholar 

  2. Carangiu ML, Zampi G, Rosai J (1985) Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates. Pathol Annu 20:1–44

    Google Scholar 

  3. Cordon-Cardo C, Reuter VE, Lloyd KO, et al (1988) Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX and LeY determinants in urothelial carcinomas. Cancer Res 48:4113–4120

    Google Scholar 

  4. Damjanov I (1987) Lectin cytochemistry and histochemistry. Lab Invest 57:5–20

    Google Scholar 

  5. Dorfman RF, Gatter KC, Pulford KAF, Mason DY (1986) An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. Am J Pathol 123:508–519

    Google Scholar 

  6. Franssila KO, Ackerman LV, Brown CL, Hedinger CE (1985) Follicular carcinoma. Semin Diagn Pathol 2:101–122

    Google Scholar 

  7. Frierson HF, Innes DJ (1985) Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease. Arch Pathol Lab Med 109:1024–1028

    Google Scholar 

  8. Gonzalez-Campora R, Sanchez Gallego F, Martin Lacave I, et al (1988) Lectin histochemistry of the thyroid gland. Cancer 62:2354–2362

    Google Scholar 

  9. Hakomori SI (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52:257–331

    Google Scholar 

  10. Hakomori SI, Nudelman E, Kannagi R, Levery SB (1982) The common structure in fucosyllactosaminolipids accumulating in human adenocarcinomas, and its possible absence in normal tissue. Biochem Biophys Res Commun 109:36–44

    Google Scholar 

  11. Hall PA, D'Ardenne AJ (1987) Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. J Clin Pathol 40:1298–1304

    Google Scholar 

  12. Hsu SM, Yang K, Jaffe ES (1985) Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 118:209–217

    Google Scholar 

  13. Kim YS, Itzkowitz SH (1988) Carbohydrate antigen expression in the adenoma-carcinoma sequence. Prog Clin Biol Res 279:241–250

    Google Scholar 

  14. Kornstein MJ, Bonner H, Gee B, Cohen R, Brooks JJ (1986) LeuM1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas. Am J Clin Pathol 85:433–437

    Google Scholar 

  15. Kotani T, Asada Y, Aratake Y, et al (1992) Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours. J Pathol (Lond) 168:41–45

    Google Scholar 

  16. Kukkonen ST, Haapiainen RT, Franssila KO, Sivula A (1990) Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients. World J Surg 148:837–841

    Google Scholar 

  17. Langle F, Soliman T, Neuhold N, et al (1994) CD15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study group on multiple endocrine neoplasia of Austria. World J Surg 18:583–587

    Google Scholar 

  18. LeBrun DP, Kamel OW, Dorfman RF, Warnke RA (1992) Enhanced staining for Leu M1 (CD15) in Hodgkin's disease using a secondary antibody for immunoglobulin M. Am J Clin Pathol 97:135–138

    Google Scholar 

  19. Livolsi VA (1986) Pathology of the thyroid. Major problems in surgical pathology, Saunders, Philadelphia

    Google Scholar 

  20. Miettinen M, Kovatich AJ (1995) HBME-1 monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma and soft tissue and bone tumors. Appl Immunohistochem 3:115–122

    Google Scholar 

  21. Neuhold N, Langle F, Gannt M, Hollenstein U, Niederle B (1992) Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinomas. J Cancer Res Clin Oncol 118:629–634

    Google Scholar 

  22. Ordonez NG (1989) The immunohistochemical diagnosis of malignant mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 13:276–291

    Google Scholar 

  23. Otis CN, Carter D, Cole S, Battifora H (1987) Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases. Am J Surg Pathol 11:445–456

    Google Scholar 

  24. Pinkus GS, Thomas P, Said JW (1985) Leu-M1 — a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol 119:244–252

    Google Scholar 

  25. Rao SK, Fraire AE (1995) Alveolar cell hyperplasia in association with adenocarcinoma of the lung. Mod Pathol 8:165–169

    Google Scholar 

  26. Rosai J, Carangiu MI, DeLellis RA (1992) Fumors of the thyroid gland. Armed Forces Institute of Pathology, Washington, DC

    Google Scholar 

  27. Sasano H, Rojas M, Silverberg SG (1989) Analysis of lectin binding in benign and malignant thyroid nodules. Arch Pathol Lab Med 113:186–189

    Google Scholar 

  28. Schröder S, Schwarz W, Rehpenning W, Loning T, Böcker W (1987) Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland. Virchows Arch [A] 411:435–439

    Google Scholar 

  29. Schröder S, Schwarz W, Rehpenning W, et al (1988) Leu-M1 immunoreactivity and prognosis of medullary carcinomas of the thyroid gland. J Cancer Res Clin Oncol 114:291–296

    Google Scholar 

  30. Scopa CD, Melachrinou M, Saradopoulou C, Merino MJ (1993) The significance of the grooved nucleus in thyroid lesions. Mod Pathol 6:691–694

    Google Scholar 

  31. Sheibani K, Battifora H, Burke JS (1986) Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of LeuM1 antigen. Am J Pathol 123:212–219

    Google Scholar 

  32. Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM (1992) Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 23:107–116

    Google Scholar 

  33. Sobrinho-Simoes M (1995) Tumours of the thyroid: a brief overview with emphasis on the most controversial issues. Curr Diagn Pathol 2:15–22

    Google Scholar 

  34. Sobrinho-Simoes M, Damjanov I (1986) Lectin histochemistry of papillary and follicular carcinoma of the thyroid gland. Arch Pathol Lab Med 110:722–729

    Google Scholar 

  35. Stanta G, Carangiu ML, Rosai J (1988) The biochemical and immunohistochemical profile of thyroid neoplasia. Pathol Annu 23:129–157

    Google Scholar 

  36. Stein H, Uchanska-Ziegler B, Gerdes J, Ziegler A, Wernet P (1982) Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int J Cancer 29:283–290

    Google Scholar 

  37. Strickler JG, Herndier BG, Rouse RV (1987) Immunohistochemical staining in malignant mesotheliomas. Am J Clin Pathol 88:610–614

    Google Scholar 

  38. Vijayakumar T, Augustine J, Mathew L, et al (1992) Tissue binding pattern of plant lectins in benign and malignant lesions of thyroid. J Exp Pathol 6:11–23

    Google Scholar 

  39. Warnock ML, Stoloff A, Thor A (1988) Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1. Am J Pathol 133:30–38

    Google Scholar 

  40. Wick MR, Loy T, Mills SE, Legier JF, Manivel JC (1990) Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases. Hum Pathol 21:759–766

    Google Scholar 

  41. Xu XC, El-Naggar AK, Lotan R (1995) Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147:815–822

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, 14 Street and Alaska Avenue, 20306-6000, Washington, DC, USA

    M. Miettinen

  2. Department of Pathology, University of Helsinki, Haartmaninkatu 3, SF-00014, Helsinki, Finland

    P. Kärkkäinen

Authors
  1. M. Miettinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Kärkkäinen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miettinen, M., Kärkkäinen, P. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Vichows Archiv A Pathol Anat 429, 213–219 (1996). https://doi.org/10.1007/BF00198336

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00198336

Key words

Search

Navigation